SHAWCITY LIMITED

Risk Rating: LOW

Justification: Based on the available 2020 financial data, Shawcity Limited exhibits a strong solvency position with net assets of £1.45 million against total liabilities of £750k. Liquidity is robust, with a healthy current ratio of approximately 2.0 and a significant cash reserve of £714k. The company demonstrated operational resilience by remaining profitable and maintaining margins during the 2020 pandemic lockdowns. Regulatory compliance appears current, with no overdue filings.

Key Concerns

1. Intra-Group Dependency and Liabilities: The company is a wholly-owned subsidiary of Ion Science Limited, with a significant current liability of £214,677 owed to group undertakings. While common in group structures, this intra-group debt represents a sizable portion (approx. 29%) of current liabilities. The terms of this debt (e.g., whether it is callable on demand) are not disclosed in the small company accounts, which introduces an element of counterparty risk dependent on the parent's financial health.
2. Security Over Assets: Bank loans totaling £133k (current and non-current) are secured by a fixed and floating charge over all company assets. In a distress scenario, these secured creditors would have priority, limiting recovery for unsecured creditors.
3. Data Staleness: The detailed financial analysis is based on accounts made up to 31 December 2020. While the overview indicates more recent filings (up to 2025) are likely submitted and compliant, the absence of detailed post-2020 financials creates a blind spot regarding the company's current performance, especially given the economic shifts and inflationary pressures in subsequent years.

Positive Indicators

1. Strong Cash Generation: Cash at bank increased substantially from £423,769 in 2019 to £714,500 in 2020, a 68.6% improvement. This occurred despite a slight reduction in trade debtors, suggesting highly effective cash collection and strong cash conversion, even during a period of declining sales.
2. Resilience During Disruption: The directors' report explicitly notes a decline in sales due to 2020 lockdowns but confirms the business remained profitable with unaffected margins and cash collection. The increase in employee headcount (from 23 to 27) during this period also suggests stability and investment rather than retrenchment.
3. Solid Equity Base: The company has accumulated retained profits of £1.45 million on a share capital of just £100. This long-term accumulation of earnings indicates a mature, historically profitable business that is not reliant on debt leverage for its asset base.

Due Diligence Notes

1. Obtain Recent Accounts: It is imperative to review the filed accounts for the years ending 2021 through 2024 to verify current solvency, liquidity, and whether the strong cash position was maintained post-pandemic.
2. Parent Company Analysis: Conduct a financial health assessment of the ultimate parent, Ion Science Holdings Limited, and the immediate parent, Ion Science Limited. Given the intra-group liabilities and the PSC status, Shawcity's stability is intrinsically linked to the broader group's strategy and solvency.
3. Intra-Group Debt Terms: Investigate the nature and terms of the £214,677 owed to group undertakings. Determine if this is structured as long-term subordinated debt or if it is callable on demand, which could impact Shawcity's liquidity.
4. Duplicate PSC Entries: The PSC register shows Ion Science Ltd listed twice with identical ownership thresholds. While likely an administrative filing error, this should be clarified with the company or verified against the Companies House register to ensure accurate ownership records.